The state of Georgia currently has 52 active clinical trials seeking participants for Diabetes research studies. These trials are conducted in various cities, including Atlanta, Augusta, Decatur and Savannah.
Closed Loop Glucose Control in Patients With Type 1 and Type 2 Diabetes
NCT05644730
Recruiting
This is a proof of concept safety study of an artificial intelligence based closed loop glucose control system designed for use in the intensive care unit setting. The type 1 and type 2 diabetic subjects in this study will have their glucose controlled to a range of 100-140 mg/dL by a novel artificial intelligence based closed loop glucose control system for a period of 24 hours. The subjects will consume three standardized meals during the 24 hour study period.
Gender:
All
Ages:
Between 18 years and 70 years
Trial Updated:
12/31/2022
Locations: Emory University, Atlanta, Georgia
Conditions: Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
Register for Updates
Dietary Oxysterols and β-Cell Function Among African Americans
NCT05072587
Recruiting
African Americans (AAs) have a higher risk of developing type 2 diabetes than the general population. AAs are also more likely to eat foods that contain cholesterol oxides/oxysterols. Dietary oxysterols can harm the cells that produce insulin and decrease insulin production. This pilot study seeks to determine if removing dietary oxysterols with a plant-based diet will improve insulin production and decrease the risk of type 2 diabetes among AAs.
Gender:
All
Ages:
18 years and above
Trial Updated:
10/08/2021
Locations: Morehouse School of Medicine, Atlanta, Georgia
Conditions: Type 2 Diabetes
Register for Updates
Continuous Monitoring and Control of Hypoglycemia
NCT03340831
Recruiting
Evaluate safety of non-adjunctive CGM use in CGM naive participants.
Gender:
All
Ages:
2 years and above
Trial Updated:
09/17/2021
Locations: Atlanta Diabetes, Atlanta, Georgia
Conditions: Diabetes
Register for Updates
Evaluation of Medtronic DUO Extended Set
NCT04823312
Recruiting
This study is a single-center, non-randomized, prospective single arm study of adult subjects with type 1 diabetes utilizing 670G insulin pump therapy with Continuous Glucose Monitoring (CGM). These subjects will be using 4 DUO Extended sets that will serve as an exploratory pilot study to assess the 7-day survival of the Duo Extended set.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
03/29/2021
Locations: Atlanta Diabetes Associates, Atlanta, Georgia
Conditions: Diabetes Mellitus, Type 1
Register for Updates